Lipoprotein‐associated phospholipase A2 is associated with risk of dementia
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Objective: High levels of the inflammatory marker lipoprotein‐associated phospholipase A2 (Lp‐PLA2) have been proposed to be a predictor of coronary heart disease and stroke. Because both inflammation and vascular disease are associated with dementia, the objective of the present study was to examine the association between Lp‐PLA2 and the risk of dementia. Methods: Within the Rotterdam Study, a population‐based prospective cohort study, we performed a case–cohort study. Of the 6,713 participants at risk for dementia, a random sample of 1,742 individuals was drawn. During follow‐up (mean, 5.7 years), 302 incident dementia cases were identified. Cox proportional hazard models were used to estimate the association of Lp‐PLA2 and dementia. Results: We found that subjects with higher levels of Lp‐PLA2 had an increased risk of dementia. Compared with the first quartile of Lp‐PLA2, age‐ and sex‐adjusted hazard ratios (HRs; 95% confidence interval [CI]) for dementia for the second, third, and fourth quartiles were 1.19 (0.78–1.81), 1.15 (0.74–1.79), and 1.56 (1.03–2.37), respectively (p value for trend 0.04). Additional adjustment for cardiovascular and inflammatory factors did not change the estimates. Interpretation: This is the first study to our knowledge that shows that Lp‐PLA2 is associated with the risk of dementia independent of cardiovascular and inflammatory factors and provides evidence for a potential role of Lp‐PLA2 in identifying subjects at risk for dementia. Ann Neurol 2006
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313 · cited 1×
“Because we could take into account only clinical stroke, we cannot rule out the possibility that the relation is mediated by subclinical vascular events such as silent brain infarcts, which are important risk factors for dementia.(14) An alternative explanation would be that Lp-PLA2 levels could directly affect the br…”
BackgroundSelf-citationRoth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090 · cited 1×
“Screen-positives (MMSE score 26 or GMS organic level 0) underwent further cognitive testing using the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX).(24) Subjects who were suspected of having dementia were subsequently examined by a neurologist and a neuropsychologist and, if possible, had a magnet…”
MethodMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Self-citationEarly inflammation and dementia: A 25‐year follow‐up of the Honolulu‐Asia aging study
Schmidt, R., Schmidt, H., Curb, J. D., Masaki, K., White, L. R., & Launer, L. J. (2002) · Annals of Neurology · doi:10.1002/ana.10265 · Cited by 710
Incidence and Risk of Dementia: The Rotterdam study
Ott, A., Breteler, M. M. B., Harskamp, F. V., Stijnen, T., & Hofman, A. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009489 · Cited by 455 · cited 3×
“In addition, the total cohort was continuously monitored for incident dementia through computerized linkage between the study database and digitalized medical records from general practitioners and the Regional Institute for Outpatient Mental Health Care.21 The diagnoses of dementia and Alzheimer’s disease were made i…”
MethodInfluentialSelf-citationSlooter, A. J. C., Cruts, M., Kalmijn, S., Hofman, A., Breteler, M. M. B., Van Broeckhoven, C., & van Duijn, C. M. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.964 · Cited by 399 · cited 1×
“A polymerase chain reaction was performed.(19) Two groups were formed on the basis of presence or absence of an APOE ε4”
MethodSelf-citationInflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10 · cited 1×
“Elevated levels of inflammatory proteins such as -1-antichymotrypsin and IL-6 were found in plasma of patients with Alzheimer’s disease years before the clinical dementia syndrome developed.(9) Furthermore, a beneficial effect of nonsteroidal antiinflammatory drugs has been suggested.”
BackgroundSelf-citation
Cited by
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Cardiovascular risk factors and future risk of Alzheimer’s disease
de Bruijn, R. F., & Ikram, M. A. (2014) · BMC Medicine · doi:10.1186/s12916-014-0130-5 · Cited by 322
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.03.031 · Cited by 262
Inflammatory markers and the risk of dementia and Alzheimer's disease: a meta-analysis
Darweesh, S. K. L., Wolters, F. J., Ikram, M. A., de Wolf, F., Bos, D., & Hofman, A. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.014 · Cited by 244
“The Cardiovascular Health Study and the Rotterdam Study also reported a statistically significant association between elevated lipoprotein-associated phospholipase A2 (Lp-PLA2) activity levels and all-cause dementia [13,27], as was the meta-analyzed HR of these two studies (Table 2).”
BackgroundZimetti, F., Adorni, M. P., Marsillach, J., Marchi, C., Trentini, A., Valacchi, G., & Cervellati, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6695796 · Cited by 49
Metadata
- Authors
- van Oijen, M., van der Meer, I. M., Hofman, A., Witteman, J. C. M., Koudstaal, P. J., & Breteler, M. M. B.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2005-12-22
- Volume
- 59
- Issue
- 1
- Pages
- 139-144
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1970903934
- Cited by
- 40
- References
- 8
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipoprotein‐associated phospholipase A2 is associated with risk of dementia. https://app.cochat.ai/papers/10.1002/ana.20721
- The paper
- van Oijen, M., van der Meer, I. M., Hofman, A., Witteman, J. C. M., Koudstaal, P. J., & Breteler, M. M. B. (2006). Lipoprotein‐associated phospholipase A2 is associated with risk of dementia. Annals of Neurology. https://doi.org/10.1002/ana.20721
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.